Loading…

Micelles based on HPMA copolymers

Polymeric micelles have been under extensive investigation during the past years as drug delivery systems, particularly for anticancer drugs. They are formed by the self-assembly of amphiphilic block copolymers in aqueous solutions and have a spherical shape and a size in the nano-range (< 200 nm...

Full description

Saved in:
Bibliographic Details
Published in:Advanced drug delivery reviews 2010-02, Vol.62 (2), p.231-239
Main Authors: Talelli, M., Rijcken, C.J.F., van Nostrum, C.F., Storm, G., Hennink, W.E.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-18d3f2bb649136fc417ad61671b3ca1cc00a970824cf77664d34454094b32ae53
cites
container_end_page 239
container_issue 2
container_start_page 231
container_title Advanced drug delivery reviews
container_volume 62
creator Talelli, M.
Rijcken, C.J.F.
van Nostrum, C.F.
Storm, G.
Hennink, W.E.
description Polymeric micelles have been under extensive investigation during the past years as drug delivery systems, particularly for anticancer drugs. They are formed by the self-assembly of amphiphilic block copolymers in aqueous solutions and have a spherical shape and a size in the nano-range (< 200 nm). Tumor accumulation of polymeric micelles upon intravenous administration can occur as a result of the leaky vasculature of tumor tissue (called the enhanced permeation and retention (EPR) effect).To benefit from the EPR effect, polymeric micelles need to have prolonged circulation times as well as high and stable drug loadings. Poly[N-(2-hydroxypropyl) methacrylamide] (pHPMA) is a hydrophilic polymer currently under investigation for its use in polymer–drug conjugates. Its biocompatibility, non-immunogenicity and the possibility for functionalization are properties that resulted in broad pharmaceutical and biomedical applications, also in the micelle technology research. Being hydrophilic, it can serve as a micellar stealth corona, while it can also be modified with hydrophobic moieties to serve as a micellar core in which hydrophobic drugs can be solubilized and retained. HPMA-based polymeric micelles have been showing very promising in vitro and in vivo results. This review summarizes the applications of pHPMA in the field of polymeric micelles, either serving as a micellar stealth corona, or, if hydrophobically rendered by derivatization, as a micellar core.
doi_str_mv 10.1016/j.addr.2009.11.029
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745634950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169409X09003846</els_id><sourcerecordid>745634950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-18d3f2bb649136fc417ad61671b3ca1cc00a970824cf77664d34454094b32ae53</originalsourceid><addsrcrecordid>eNqFkMFLwzAchYMobk7_AQ9ST55a80vSpAEvMtQJG3pQ8BbSJIWOdpnJJuy_N2XTo57e5XuPx4fQJeACMPDbZaGtDQXBWBYABSbyCI2hEiSviGTHaJwgmTMsP0boLMYlxkAEx6dolCqYcUnH6HrRGtd1Lma1js5mfpXNXhf3mfFr3-16F-I5Oml0F93FISfo_fHhbTrL5y9Pz9P7eW5oJTY5VJY2pK45k0B5YxgIbTlwATU1GozBWEuBK8JMIwTnzFLGynSO1ZRoV9IJutnvroP_3Lq4UX0bh2965fw2KsFKTpks8f8kZUQCAE8k2ZMm-BiDa9Q6tL0OOwVYDQ7VUg0O1eBQAajkMJWuDvPbunf2t_IjLQF3e8AlHV-tCyqa1q2Ms21wZqOsb__a_wbnIH8D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734291116</pqid></control><display><type>article</type><title>Micelles based on HPMA copolymers</title><source>ScienceDirect Journals</source><creator>Talelli, M. ; Rijcken, C.J.F. ; van Nostrum, C.F. ; Storm, G. ; Hennink, W.E.</creator><creatorcontrib>Talelli, M. ; Rijcken, C.J.F. ; van Nostrum, C.F. ; Storm, G. ; Hennink, W.E.</creatorcontrib><description>Polymeric micelles have been under extensive investigation during the past years as drug delivery systems, particularly for anticancer drugs. They are formed by the self-assembly of amphiphilic block copolymers in aqueous solutions and have a spherical shape and a size in the nano-range (&lt; 200 nm). Tumor accumulation of polymeric micelles upon intravenous administration can occur as a result of the leaky vasculature of tumor tissue (called the enhanced permeation and retention (EPR) effect).To benefit from the EPR effect, polymeric micelles need to have prolonged circulation times as well as high and stable drug loadings. Poly[N-(2-hydroxypropyl) methacrylamide] (pHPMA) is a hydrophilic polymer currently under investigation for its use in polymer–drug conjugates. Its biocompatibility, non-immunogenicity and the possibility for functionalization are properties that resulted in broad pharmaceutical and biomedical applications, also in the micelle technology research. Being hydrophilic, it can serve as a micellar stealth corona, while it can also be modified with hydrophobic moieties to serve as a micellar core in which hydrophobic drugs can be solubilized and retained. HPMA-based polymeric micelles have been showing very promising in vitro and in vivo results. This review summarizes the applications of pHPMA in the field of polymeric micelles, either serving as a micellar stealth corona, or, if hydrophobically rendered by derivatization, as a micellar core.</description><identifier>ISSN: 0169-409X</identifier><identifier>EISSN: 1872-8294</identifier><identifier>DOI: 10.1016/j.addr.2009.11.029</identifier><identifier>PMID: 20004693</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acrylamides - chemistry ; Animals ; Drug delivery ; Drug Delivery Systems - methods ; Drug Delivery Systems - trends ; Drug targeting ; EPR effect ; HEMAm ; HPMA ; Humans ; Micelle core ; Micelle corona ; Micelles ; N-(2-hydroxylpropyl) methacrylamide ; Nanomedicine - methods ; Nanomedicine - trends ; Polymeric micelles ; Polymers - chemistry</subject><ispartof>Advanced drug delivery reviews, 2010-02, Vol.62 (2), p.231-239</ispartof><rights>2009 Elsevier B.V.</rights><rights>Copyright 2009 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-18d3f2bb649136fc417ad61671b3ca1cc00a970824cf77664d34454094b32ae53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20004693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talelli, M.</creatorcontrib><creatorcontrib>Rijcken, C.J.F.</creatorcontrib><creatorcontrib>van Nostrum, C.F.</creatorcontrib><creatorcontrib>Storm, G.</creatorcontrib><creatorcontrib>Hennink, W.E.</creatorcontrib><title>Micelles based on HPMA copolymers</title><title>Advanced drug delivery reviews</title><addtitle>Adv Drug Deliv Rev</addtitle><description>Polymeric micelles have been under extensive investigation during the past years as drug delivery systems, particularly for anticancer drugs. They are formed by the self-assembly of amphiphilic block copolymers in aqueous solutions and have a spherical shape and a size in the nano-range (&lt; 200 nm). Tumor accumulation of polymeric micelles upon intravenous administration can occur as a result of the leaky vasculature of tumor tissue (called the enhanced permeation and retention (EPR) effect).To benefit from the EPR effect, polymeric micelles need to have prolonged circulation times as well as high and stable drug loadings. Poly[N-(2-hydroxypropyl) methacrylamide] (pHPMA) is a hydrophilic polymer currently under investigation for its use in polymer–drug conjugates. Its biocompatibility, non-immunogenicity and the possibility for functionalization are properties that resulted in broad pharmaceutical and biomedical applications, also in the micelle technology research. Being hydrophilic, it can serve as a micellar stealth corona, while it can also be modified with hydrophobic moieties to serve as a micellar core in which hydrophobic drugs can be solubilized and retained. HPMA-based polymeric micelles have been showing very promising in vitro and in vivo results. This review summarizes the applications of pHPMA in the field of polymeric micelles, either serving as a micellar stealth corona, or, if hydrophobically rendered by derivatization, as a micellar core.</description><subject>Acrylamides - chemistry</subject><subject>Animals</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Delivery Systems - trends</subject><subject>Drug targeting</subject><subject>EPR effect</subject><subject>HEMAm</subject><subject>HPMA</subject><subject>Humans</subject><subject>Micelle core</subject><subject>Micelle corona</subject><subject>Micelles</subject><subject>N-(2-hydroxylpropyl) methacrylamide</subject><subject>Nanomedicine - methods</subject><subject>Nanomedicine - trends</subject><subject>Polymeric micelles</subject><subject>Polymers - chemistry</subject><issn>0169-409X</issn><issn>1872-8294</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkMFLwzAchYMobk7_AQ9ST55a80vSpAEvMtQJG3pQ8BbSJIWOdpnJJuy_N2XTo57e5XuPx4fQJeACMPDbZaGtDQXBWBYABSbyCI2hEiSviGTHaJwgmTMsP0boLMYlxkAEx6dolCqYcUnH6HrRGtd1Lma1js5mfpXNXhf3mfFr3-16F-I5Oml0F93FISfo_fHhbTrL5y9Pz9P7eW5oJTY5VJY2pK45k0B5YxgIbTlwATU1GozBWEuBK8JMIwTnzFLGynSO1ZRoV9IJutnvroP_3Lq4UX0bh2965fw2KsFKTpks8f8kZUQCAE8k2ZMm-BiDa9Q6tL0OOwVYDQ7VUg0O1eBQAajkMJWuDvPbunf2t_IjLQF3e8AlHV-tCyqa1q2Ms21wZqOsb__a_wbnIH8D</recordid><startdate>20100217</startdate><enddate>20100217</enddate><creator>Talelli, M.</creator><creator>Rijcken, C.J.F.</creator><creator>van Nostrum, C.F.</creator><creator>Storm, G.</creator><creator>Hennink, W.E.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100217</creationdate><title>Micelles based on HPMA copolymers</title><author>Talelli, M. ; Rijcken, C.J.F. ; van Nostrum, C.F. ; Storm, G. ; Hennink, W.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-18d3f2bb649136fc417ad61671b3ca1cc00a970824cf77664d34454094b32ae53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acrylamides - chemistry</topic><topic>Animals</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Delivery Systems - trends</topic><topic>Drug targeting</topic><topic>EPR effect</topic><topic>HEMAm</topic><topic>HPMA</topic><topic>Humans</topic><topic>Micelle core</topic><topic>Micelle corona</topic><topic>Micelles</topic><topic>N-(2-hydroxylpropyl) methacrylamide</topic><topic>Nanomedicine - methods</topic><topic>Nanomedicine - trends</topic><topic>Polymeric micelles</topic><topic>Polymers - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talelli, M.</creatorcontrib><creatorcontrib>Rijcken, C.J.F.</creatorcontrib><creatorcontrib>van Nostrum, C.F.</creatorcontrib><creatorcontrib>Storm, G.</creatorcontrib><creatorcontrib>Hennink, W.E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Advanced drug delivery reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talelli, M.</au><au>Rijcken, C.J.F.</au><au>van Nostrum, C.F.</au><au>Storm, G.</au><au>Hennink, W.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Micelles based on HPMA copolymers</atitle><jtitle>Advanced drug delivery reviews</jtitle><addtitle>Adv Drug Deliv Rev</addtitle><date>2010-02-17</date><risdate>2010</risdate><volume>62</volume><issue>2</issue><spage>231</spage><epage>239</epage><pages>231-239</pages><issn>0169-409X</issn><eissn>1872-8294</eissn><abstract>Polymeric micelles have been under extensive investigation during the past years as drug delivery systems, particularly for anticancer drugs. They are formed by the self-assembly of amphiphilic block copolymers in aqueous solutions and have a spherical shape and a size in the nano-range (&lt; 200 nm). Tumor accumulation of polymeric micelles upon intravenous administration can occur as a result of the leaky vasculature of tumor tissue (called the enhanced permeation and retention (EPR) effect).To benefit from the EPR effect, polymeric micelles need to have prolonged circulation times as well as high and stable drug loadings. Poly[N-(2-hydroxypropyl) methacrylamide] (pHPMA) is a hydrophilic polymer currently under investigation for its use in polymer–drug conjugates. Its biocompatibility, non-immunogenicity and the possibility for functionalization are properties that resulted in broad pharmaceutical and biomedical applications, also in the micelle technology research. Being hydrophilic, it can serve as a micellar stealth corona, while it can also be modified with hydrophobic moieties to serve as a micellar core in which hydrophobic drugs can be solubilized and retained. HPMA-based polymeric micelles have been showing very promising in vitro and in vivo results. This review summarizes the applications of pHPMA in the field of polymeric micelles, either serving as a micellar stealth corona, or, if hydrophobically rendered by derivatization, as a micellar core.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>20004693</pmid><doi>10.1016/j.addr.2009.11.029</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-409X
ispartof Advanced drug delivery reviews, 2010-02, Vol.62 (2), p.231-239
issn 0169-409X
1872-8294
language eng
recordid cdi_proquest_miscellaneous_745634950
source ScienceDirect Journals
subjects Acrylamides - chemistry
Animals
Drug delivery
Drug Delivery Systems - methods
Drug Delivery Systems - trends
Drug targeting
EPR effect
HEMAm
HPMA
Humans
Micelle core
Micelle corona
Micelles
N-(2-hydroxylpropyl) methacrylamide
Nanomedicine - methods
Nanomedicine - trends
Polymeric micelles
Polymers - chemistry
title Micelles based on HPMA copolymers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A06%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Micelles%20based%20on%20HPMA%20copolymers&rft.jtitle=Advanced%20drug%20delivery%20reviews&rft.au=Talelli,%20M.&rft.date=2010-02-17&rft.volume=62&rft.issue=2&rft.spage=231&rft.epage=239&rft.pages=231-239&rft.issn=0169-409X&rft.eissn=1872-8294&rft_id=info:doi/10.1016/j.addr.2009.11.029&rft_dat=%3Cproquest_cross%3E745634950%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-18d3f2bb649136fc417ad61671b3ca1cc00a970824cf77664d34454094b32ae53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734291116&rft_id=info:pmid/20004693&rfr_iscdi=true